X4 Pharmaceuticals Inc (NASDAQ:XFOR) has a beta value of 0.50 and has seen 10.88 million shares traded in the last trading session. The company, currently valued at $195.65M, closed the last trade at $1.16 per share which meant it gained $0.03 on the day or 3.10% during that session. The XFOR stock price is -122.41% off its 52-week high price of $2.58 and 50.86% above the 52-week low of $0.57. The 3-month trading volume is 2.48 million shares.

X4 Pharmaceuticals Inc (NASDAQ:XFOR) trade information

Sporting 3.10% in the green in last session, the stock has traded in the red over the last five days, when the XFOR stock price touched $1.16 or saw a rise of 16.55%. Year-to-date, X4 Pharmaceuticals Inc shares have moved 38.94%, while the 5-day performance has seen it change -7.54%. Over the past 30 days, the shares of X4 Pharmaceuticals Inc (NASDAQ:XFOR) have changed -17.38%.

X4 Pharmaceuticals Inc (XFOR) estimates and forecasts

Figures show that X4 Pharmaceuticals Inc shares have outperformed across the wider relevant industry. The company’s shares have gained 54.28% over the past 6 months, with this year growth rate of 17.54%, compared to 12.90% for the industry. Other than that, the company has, however, increased its growth outlook for the 2024 fiscal year revenue. Growth estimates for the current quarter are 0.00% and 87.90% for the next quarter.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 73.95% over the past 5 years.

XFOR Dividends

X4 Pharmaceuticals Inc is expected to release its next earnings report in May this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.